Related Experiment Video
Updated: Aug 18, 2026
Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Published on: May 20, 2020
Experimental approaches for the prevention of hematogenous metastasis
Abstract:
With improvements in surgical procedures and cure rates, the probable course of cancer for the majority of patients is now largely determined by metastasis rather than growth of the primary tumor itself. Thus, metastasis has received increasing attention over the past decade. These studies have led to the identification of several of the molecular events crucial for metastatic dissemination, information which is now being used to design therapeutic strategies to inhibit metastasis formation. Even though the molecular events involved in the dissemination of malignant disease are only partially known, several promising agents are now being tested for their capacity to limit the spread of cancer. A few clinical trials have shown benefit in prolonging survival and disease-free state, particularly when such therapy is employed on an adjuvant basis.
Insights
Cancer metastasis, the spread of cancer cells, is now a primary determinant of patient outcomes. Research is identifying molecular targets for new therapies aimed at inhibiting cancer spread and improving survival rates.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Cancer metastasis, rather than primary tumor growth, increasingly dictates patient prognosis due to advancements in surgical procedures and cure rates.
- Metastasis has become a major focus of cancer research over the last decade.
- Understanding the molecular mechanisms of metastatic dissemination is critical for developing effective treatments.
Purpose of the Study:
- To review the current understanding of molecular events in cancer metastasis.
- To highlight the development of therapeutic strategies targeting metastasis.
- To discuss the potential of novel anti-metastasis agents in clinical trials.
Main Methods:
- Review of recent scientific literature on cancer metastasis.
- Analysis of identified molecular pathways involved in cancer dissemination.
- Evaluation of ongoing clinical trials for anti-metastasis therapies.
Main Results:
- Several molecular events crucial for metastatic dissemination have been identified.
- Promising therapeutic agents targeting metastasis are under investigation.
- Early clinical trials show potential benefits of anti-metastasis therapy, especially in adjuvant settings.
Conclusions:
- Inhibiting cancer metastasis is a key strategy for improving patient survival and disease-free states.
- Targeted therapies are being developed based on molecular insights into cancer spread.
- Adjuvant anti-metastasis therapy shows promise in clinical settings.
